Cookie Einstellungen
Diese Webseite verwendet ausschließlich notwendige Cookies, die für die Funktion erforderlich sind. Marketing- und Statistik-Cookies kommen nicht zum Einsatz. Weitere Informationen finden Sie in unserer Datenschutzerklärung.
 Notwendig   Details einblenden
      OK      
Bitte logge Dich ein, um diese Funktion zu nutzen!
      OK      
x
Impact News +++ How Do Investors Really Feel About Ondas Inc? (Benzinga) +++ ONDAS Aktie +3,04%

IRONWOOD Aktie

 >IRONWOOD Aktienkurs 
3.34 EUR    -15.2%    (TradegateBSX)
Ask: 3.44 EUR / 1500 Stück
Bid: 3.34 EUR / 1600 Stück
Tagesumsatz: 2824 Stück
Realtime Kurs von 7:30 bis 22 Uhr!
IRONWOOD Aktie über LYNX handeln
>IRONWOOD Performance
1 Woche: +4,8%
1 Monat: +1,0%
3 Monate: +50,0%
6 Monate: +325,8%
1 Jahr: +110,6%
laufendes Jahr: +45,6%
>IRONWOOD Aktie
Name:  IRONWOOD PHARMA.A DL-,001
Land:  USA
Sektor:  Gesundheit
ISIN/ Wkn:  US46333X1081 / A0X789
Symbol/ Ticker:  I76 (Frankfurt) / IRWD (NASDAQ)
Kürzel:  FRA:I76, ETR:I76, I76:GR, NASDAQ:IRWD
Index:  -
Webseite:  http://www.ironwoodpharma..
Profil:  Ironwood Pharmaceuticals Inc. is a healthcare and pharmaceuticals company specializing in the development and commercialization of drugs for gastrointestinal conditions. Headquartered in Cambridge, Ma..
>Volltext..
Marktkapitalisierung:  618.71 Mio. EUR
Unternehmenswert:  1009.45 Mio. EUR
Umsatz:  286.5 Mio. EUR
EBITDA:  124.58 Mio. EUR
Nettogewinn:  24.92 Mio. EUR
Gewinn je Aktie:  0.15 EUR
Schulden:  505.61 Mio. EUR
Liquide Mittel:  118.67 Mio. EUR
Operativer Cashflow:  57.2 Mio. EUR
Bargeldquote:  0.58
Umsatzwachstum:  -15%
Gewinnwachstum:  -
Dividende je Aktie:  -
Dividendenrendite:  -
Dividendenschätzung:  -
Insiderhandel:  -
Suchwörter:  IRONWOOD
Letzte Datenerhebung:  20.02.26
>IRONWOOD Kennzahlen
Aktien/ Unternehmen:
Aktien: 162.68 Mio. St.
Frei handelbar: 96.32%
Rückkaufquote: -0.04%
Mitarbeiter: 253
Umsatz/Mitarb.: 1.17 Mio. EUR
Analysten:
Analystenrating: Buy
Kursziel: 101.04%
Bewertung:
KGV: 27.36
KGV lG: 36.24
KUV: 2.36
KBV: -
PEG-Ratio: -
EV/EBITDA: 8.1
Rentabilität:
Bruttomarge: 99.44%
Gewinnmarge: 8.7%
Operative Marge: 42.92%
Managementeffizenz:
Gesamtkaprendite: 7.51%
Eigenkaprendite: -
>IRONWOOD Peer Group
Gesundheit
 
20.02.26 - 18:16
Ironwood vs. Bausch Health: Which GI Drug Stock is a Better Pick Now? (Zacks)
 
IRWD has the edge over BHC with high Linzess demand and upbeat 2026 revenue outlook offsetting pipeline and pricing risks....
18.02.26 - 22:24
Ironwood Pharmaceuticals to Host Fourth Quarter and Full Year 2025 Investor Update Call (Business Wire)
 
BOSTON--(BUSINESS WIRE)--Ironwood Pharmaceuticals, Inc. (Nasdaq: IRWD), today announced it will host its fourth quarter and full year 2025 investor update conference call and webcast at 8:30 a.m. Eastern Time on Wednesday, February 25, 2026. Individuals interested in participating in the call should dial (888) 596-4144 (U.S. and Canada) or (646) 968-2525 (international) using conference ID number and event passcode 8188306. To access the webcast, please visit the Investors & Media section of Ironwood's website at www.ironwoodpharma.com. The call will be available for replay via telephone starting Wednesday, February 25, 2026, at approximately 11:30 a.m. Eastern Time, running through 11:59 p.m. Eastern Time on Wednesday, March 11, 2026. To listen to the replay, dial (800) 770-2030 (U.S. and Canada) or (609) 800-9909 (international) using conference ID number 8188306. About Ironwood Pharmaceuticals Ironwood Pharmaceuticals (Nasdaq: IRWD) is a biotechnology company developing and commercializing life-changi...
12.02.26 - 18:15
IRWD Rises 307% in 6 Months: Is This an Indication to Buy the Stock? (Zacks)
 
Ironwood surges 307% in six months on rising Linzess demand and an upbeat 2026 revenue outlook. The company is also making good pipeline progress....
04.02.26 - 19:54
Topics To Watch In Google′s Earnings Call: ′Ironwood,′ Gemini 3, And YouTube Shorts (Benzinga)
 
Alphabet (GOOGL) reports Q4 results today. As a major player in digital advertising and AI, Google's earnings are a key indicator for the global economy. Traders are betting on mentions of Ironwood TPU, Gemini 3 Pro, and YouTube Shorts. Importance Rank:  1 read more...
28.01.26 - 22:18
Park Dental Partners Expands Presence in Arizona with Addition of Ironwood Dental (GlobeNewswire EN)
 
Park Dental Partners is pleased to announce that Ironwood Dental of Tucson, Arizona, has joined its network of affiliated dental practices....
26.01.26 - 10:00
Zacks.com featured highlights include IPG Photonics, Ironwood and Science Applications (Zacks)
 
IPG Photonics, Ironwood and Science Applications have been highlighted in this Screen of The Week article....
08.01.26 - 00:01
Insiderhandel: Principal Accounting Officer verkauft Aktien von Ironwood Pharmaceuticals im Wert von 162914 USD (Insiderkauf)
 
Silver, Ronald - Vorstand - Tag der Transaktion: 2026-01-05...
05.01.26 - 18:15
Ironwood Stock Rises 27% on Upbeat Revenue Guidance for 2026 (Zacks)
 
IRWD shares jump on upbeat 2026 revenue guidance amid rising Linzess demand in the United States. The company also provides a key pipeline update....
02.01.26 - 18:06
Ironwood Pharmaceuticals: Aktie schießt nach starker Prognose für 2026 in die Höhe (Investing.com DE)
 
Um den gesamten Artikel unter de.investing.com zu lesen, klicken Sie bitte auf die Überschrift...
02.01.26 - 13:33
Ironwood beats on 2026 outlook thanks to AbbVie-partnered Linzess (SeekingAlpha)
 
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...
23.12.25 - 13:57
Ironwood rises after settling Ferring lawsuit (SeekingAlpha)
 
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...
10.12.25 - 19:01
Why Is Ironwood (IRWD) Up 24.9% Since Last Earnings Report? (Zacks)
 
Ironwood (IRWD) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues....
01.12.25 - 09:06
Samsung′s HBM3E performance leap propels it to become primary supplier of Google′s Ironwood TPU (Digitimes)
 
Media reports show that Google's Ironwood TPU is equipped with HBM3E from Samsung Electronics and SK Hynix. According to the Korea Economic Daily, Samsung supplied over 60% of the total HBM delivered to Google via Broadcom in 2025. This was possible by a redesign of the DRAM used in HBM, which boosted HBM3E performance....
01.12.25 - 02:06
Research Insight: Gemini threatens OpenAI′s AI crown: Ecosystem advantage signals strategic shift in tech landscape (Digitimes)
 
Google has launched Gemini 3, a new generative AI model that has quickly outperformed competing models, including OpenAI's recently released GPT-5.1, across most AI benchmark leaderboards. Launched on November 19, Gemini 3 introduces several novel features such as Deep Think mode, Nano Banana, and Antigravity, and is supported by Google's seventh-generation TPU Ironwood hardware unveiled the same month. This marks a strategic shift for Google from a defensive to an offensive approach in the AI arena....
28.11.25 - 05:06
Meta′s Google TPU shift opens new AI supply chain for Taiwan PCB makers (Digitimes)
 
Recent market rumors indicate that Meta is negotiating to deploy Google's seventh-generation TPU "Ironwood" in its data centers by 2027, with procurement potentially reaching tens of billions of US dollars. This move signals confidence that Google will become a leading ASIC chip supplier, challenging Nvidia's dominance and securing the second spot in the AI accelerator market....
27.11.25 - 19:45
IRWD vs. PBYI: Which Small-Cap Biotech Stock Is the Better Pick? (Zacks)
 
Ironwood and Puma Biotechnology are advancing therapies for gastrointestinal disorders and cancer, respectively. Rising sales of key drugs fuel 2026 prospects....
27.11.25 - 17:06
How Google put together the pieces for its AI comeback (CNBC)
 
The company's Gemini 3 and Ironwood AI chip are driving Wall Street's excitement behind Alphabet's AI comeback, but challenges remain....
27.11.25 - 11:00
Google Ironwood: Was hinter der siebten Generation der leistungsstarken TPUs steckt (IT-Times)
 
MOUNTAIN VIEW, Kalifornien (IT-Times) - Der US-amerikanische Technologiekonzern Google, eine Unit von Alphabet, hat eine neue Generation von TPUs entwickelt, die auch für den KI-Einsatz geeignet si......
24.11.25 - 23:33
Short Bowel Syndrome Market to Register Stunning Growth at a CAGR of 5% During the Forecast Period (2025-2034) Owing to the Launch of Novel GLP-2 Analogues | DelveInsight (PR Newswire)
 
The short bowel syndrome market is poised for significant change, with next-generation GLP-2 analogues such as apraglutide (Ironwood Pharmaceuticals), glepaglutide (Zealand Pharma), and sonefpeglutide (Hanmi Pharmaceutical), among others, expected to enter the market from 2026.......
>Behalte deine Investments mit realtime Kursen & News im Blick. Finde neue spannende Aktien! Registriere Dich und werde Mitglied!
Zitat des Tages: Man glaubt gar nicht, wie schwer es oft ist, eine Tat in einen Gedanken umzusetzen! - Karl Kraus
Partner:    >TradegateBSX Börse | >Dukascopy | >TradingView | >Boersentreff- Partner

Börsentreff auf Facebook | Börsentreff auf X | Börsentreff auf Instagram

Copyright @ Boersentreff.de - Die Märkte im Blick!